Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$8.8 - $13.17 $197,674 - $295,837
-22,463 Reduced 42.4%
30,519 $305,000
Q1 2024

May 15, 2024

BUY
$11.47 - $16.17 $443,097 - $624,663
38,631 Added 269.19%
52,982 $643,000
Q4 2023

Feb 14, 2024

SELL
$7.06 - $14.49 $74,518 - $152,941
-10,555 Reduced 42.38%
14,351 $205,000
Q3 2023

Nov 15, 2023

SELL
$7.43 - $14.96 $136,310 - $274,456
-18,346 Reduced 42.42%
24,906 $193,000
Q2 2023

Aug 14, 2023

BUY
$11.63 - $15.63 $7,036 - $9,456
605 Added 1.42%
43,252 $618,000
Q1 2023

May 15, 2023

BUY
$12.54 - $19.38 $352,474 - $544,733
28,108 Added 193.33%
42,647 $624,000
Q4 2022

Feb 14, 2023

SELL
$13.77 - $22.04 $266,311 - $426,253
-19,340 Reduced 57.09%
14,539 $244,000
Q3 2022

Nov 14, 2022

BUY
$13.74 - $30.13 $465,497 - $1.02 Million
33,879 New
33,879 $502,000
Q3 2021

Nov 15, 2021

SELL
$50.93 - $85.55 $1.05 Million - $1.76 Million
-20,532 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$42.76 - $63.33 $697,843 - $1.03 Million
16,320 Added 387.46%
20,532 $1.27 Million
Q1 2021

May 17, 2021

BUY
$33.36 - $62.2 $140,512 - $261,986
4,212 New
4,212 $205,000

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $96.1M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.